Table of contents

Original research

• Classifying and quantifying changes in papilloedema using machine learning (26 June, 2024)

  Joseph Branco, Jui-Kai Wang, Tobias Elze, Mona K Garvin, Louis R Pasquale, Randy Kardon, Brian Woods, David Szanto, Mark J Kupersmith
• Predictions for functional outcome and mortality in acute ischaemic stroke following successful endovascular thrombectomy (25 June, 2024)

  Minyan Zeng, Luke Smith, Alix Bird, Vincent Quoc-Nam Trinh, Stephen Bacchi, Jackson Harvey, Mark Jenkinson, Rebecca Scroop, Timothy Kleinig, Jim Jannes, Lyle J Palmer
• Planned dose reduction of ocrelizumab in relapsing-remitting multiple sclerosis: a single-centre observational study (21 June, 2024)

  Trung Dang Quoc Tran, Leanne Hall, Clare Heal, Nagaraja Haleagrahara, Sharon Edwards, Mike Boggild
• Clinical drivers of hospitalisation in patients with mitochondrial diseases (11 June, 2024)

  Sameen Haque, Karen Crawley, Ryan Davis, Deborah Schofield, Rupendra Shrestha, Carolyn M Sue
• Illness perceptions, experiences of stigma and engagement in functional neurological disorder (FND): exploring the role of multidisciplinary group education sessions (5 June, 2024)

  Cate Bailey, Niruj Agrawal, Sarah Cope, Barnaby Proctor, Bridget Mildon, Matt Butler, Kate Holt, Mark Edwards, Norman Poole, Timothy R Nicholson
• Heartbeat evoked potentials and autonomic arousal during dissociative seizures: insights from electrophysiology and neuroimaging (5 June, 2024)

  Vera Flasbeck, Johannes Jungilligens, Isabell Lemke, Jule Beckers, Hilal Öztürk, Jörg Wellmer, Corinna Seliger, Georg Juckel, Stoyan Popkirov
• Evaluation of an ambulatory care pathway for patients with nitrous oxide-induced myeloneuropathy (3 June, 2024)

  Safiya A Zaloum, Alvar Paris, Devan Mair, Charles Gutteridge, Ruth M Ayling, Barbara L Onen, Joseph Walton, Anna Workman, Nelia Villanueva, Alastair J Noyce
• Treating benign paroxysmal positional vertigo in acute traumatic brain injury: a prospective, randomised clinical trial assessing safety, feasibility, and efficacy (28 May, 2024)

  Rebecca M Smith, Caroline Burgess, Jenna Beattie, Abby Newdick, Vassilios Tahtis, Bithi Sahu, John F Golding, Jonathan Marsden, Barry M Seemungal
• Illness perception in functional neurological disorder: low illness coherence and personal control (23 May, 2024)

  Andreas Joos, Stoyan Popkirov, Claas Lahmann, Michael Jöbges, Christoph Herrmann, Philipp Maner, Kai Schörner, Gunnar Birke, Armin Hartmann
• Cross-sectional evaluation of health resource use in patients with functional neurological disorders referred to a tertiary neuroscience centre (22 May, 2024)

  Brian William O'Mahony, Robert Nelson-Sice, Glenn Nielsen, Rachael Hunter, Sarah Cope, Niruj Agarwal, Mark J Edwards, Mahinda Yogarajah
• Long-term follow-up of relapse and remission of CIDP in a Chinese cohort (16 May, 2024)

  Jingwen Niu, Lei Zhang, Nan Hu, Liying Cui, Mingsheng Liu
• Educational attainment, severity and short-term prognosis of intracerebral haemorrhage (8 May, 2024)

  Nirupama Yechoor, Pamela Rist, Alena Ganbold, Christina Kourkoulis, Samantha Mora, Ernst Mayerhofer, Livia Parodi, Lindsay Rosenfeld, Christopher D Anderson, Jonathan Rosand
• Increased screen time and its association to migraine and tension-type headache: a cross-sectional investigation among Bangladeshi students (8 May, 2024)

  Simanta Roy, Mohammad Azmain Iktidar, Sreshtha Chowdhury, Orindom Shing Pulock, Susmita Dey Pinky, Azaz Bin Sharif
• Tolerability of electrodiagnostic studies in patients: a prospective study (30 April, 2024)

  Chin-Hen Chang, Timithy Mark McClellan, Kevin David Lopez, Thomas Wasser, Somkiat Hemtasilpa
• Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic (30 April, 2024)

  Louise Rath, Wei Zhen Yeh, Angie Roldan, Robb Wesselingh, Michael Zhong, Tracie Tan, Nabil Seery, Francesca Bridge, YiChao Foong, Olga Skibina, Cassie Nesbitt, Helmut Butzkueven, Mastura Monif, Anneke van der Walt
• Long-term follow-up study of SWEDD patients with mild parkinsonian signs (24 April, 2024)

  Shoichi Sasaki
• The precision by the Face Arm Speech Time (FAST) algorithm in stroke capture, sex and age differences: a stroke registry study (15 April, 2024)

  Guri Hagberg, Haakon Ihle-Hansen, Tamar Abzhandadze, Malin Reinholdsson, Adam Viktorisson, Hege Ihle-Hansen, Katharina Stibrant Sunnerhagen
• Shared genetic aetiology of Alzheimer’s disease and age-related macular degeneration by APOC1 and APOE genes (15 April, 2024)

  Xueli Zhang, Zhuoting Zhu, Yu Huang, Xianwen Shang, Terence J O'Brien, Patrick Kwan, Jason Ha, Wei Wang, Shunming Liu, Xiayin Zhang, Katerina Kiburg, Yining Bao, Jing Wang, Honghua Yu, Mingguang He, Lei Zhang
• Demographics of focused ultrasound thalamotomy for essential tremor and trends in deep brain stimulation surgery after its introduction in the USA (10 April, 2024)

  Diwas Gautam, Vishal Venkatraman, Joshua Horns, Lexie Zidanyue Yang, Hui-Jie Lee, Panagiotis Kassavetis, Jumana Alshaikh, Paolo Moretti, Ben Shofty, Shervin Rahimpour
• Network analysis of stroke systems of care in Korea (9 April, 2024)

  Jihoon Kang, Hyunjoo Song, Seong Eun Kim, Jun Yup Kim, Hong-Kyun Park, Yong-Jin Cho, Kyung Bok Lee, Juneyoung Lee, Ji Sung Lee, Ah Rum Choi, Mi Yeon Kang, Philip B Gorelick, Hee-Joon Bae
• The Lasting impact of the COVID-19 pandemic on outpatient neurology consultations (13 March, 2024)

  Sean YW Tan, Nushan Gunawardana, Rhys C Roberts
• Estimating the cost of visiting hospital outpatient (17 February, 2024)

  Manoj Liyana Arachige, Wai Chung Tse, Roland Zhang, Henry Ma, Shaloo Singhal, Thanh Phan
• Non-invasive neuromodulation of the right temporoparietal junction using theta-burst stimulation in functional neurological disorder (14 February, 2024)

  Janine Bühler, Samantha Weber, Serafeim Loukas, Sebastian Walther, Selma Aybek
• Inflammatory markers and functional outcome score in different subgroups of ischaemic stroke: a prospective cohort study (10 February, 2024)

  Mohammad Sadegh Fakhari, Leila Poorsaadat, Amir Almasi-Hashiani, Mohsen Ebrahimi-Monfared
• Mixed methods system for the assessment of post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an exploratory study (10 February, 2024)

  Barbara Stussman, Brice Calco, Gina Norato, Angelique Gavin, Snigdha Chigurupati, Avindra Nath, Brian Walitt
• Impaired mobility and MRI markers of vascular brain injury: Atherosclerosis Risk in Communities and UK Biobank studies (24 January, 2024)

  Richa Sharma, Adam de Havenon, Cyprien Rivier, Seyedmehdi Payabvash, Rachel Forman, Harlan Krumholz, Guido J Falcone, Kevin N Sheth, Walter N Kernan
• Cognitive impairment and liver fibrosis in non-alcoholic fatty liver disease (22 January, 2024)

  Neal S Parikh, Farah Wahbeh, Christopher Tapia, Mallory Ianelli, Vanessa Liao, Abhishek Jaywant, Hooman Kamel, Sonal Kumar, Costantino Iadecola
• Levodopa use in Australia: an analysis of Pharmaceutical Benefits Scheme 10% data (17 January, 2024)

  Andrew Evans, Benjamin J Waterhouse
• Poor haemorrhagic stroke outcomes during the COVID-19 pandemic are driven by socioeconomic disparities: analysis of nationally representative data (12 January, 2024)

  Abdulaziz T Bako, Thomas Potter, Alan P Pan, Karim A Borei, Taya Prince, Gavin W Britz, Farhaan S Vahidy
• Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study (10 January, 2024)

  Jason Charles Ray, Linda Dalic, Josephine Baker, Shuli Cheng, Elspeth Jane Hutton, Manjit Matharu